Table 1

Demographic and clinical characteristics at the time of biopsy
ILAR subtype JIA patient study ID M/F Disease duration (months) No. of swollen joints VAS* pain (parent) VAS* global physician WCC* Hb* ESR* CRP* (mg/l) PC* ANA* RF (+/−)
Oligoarticular (n = 7) 1 F 4 1 5 1.9 7.5 11 8 0 407 0 -
2 M 4 1 0 0.8 12 11 11 0 415 0 -
3 F 6 3 3.6 2.9 12.1 11 10 5.7 453 0 -
4 F 10 2 0.3 1.9 6.9 10.7 4 4 315 0 -
5 F 5 3 7.5 3 12.8 10.6 37 26 407 80 -
6 M 20 1 1.4 1.9 5.6 14.1 5 0 249 0 -
7 F 4 3 4.3 1.8 9.1 8.9 62 66.5 460 0 -
Mean values 7.6 2 3.2 2 9.4 11 19.6 14.6 386.6 11.4
Polyarticular (n = 8) 8 F 2 24 8.7 7.5 12.9 8.3 38 27.5 570 160 -
9 F 2 9 8.3 3.3 13.9 10.4 22 36.1 232 0 -
10 F 2 24 4.7 5.7 12.2 10.5 30 67.3 601 0 -
11 F 2 6 9 4.8 9.9 11.1 26 32.1 446 80 -
12 F 1 2 7.1 1.5 11.2 10.4 96 47.4 522 ND -
13 F 4 15 9.8 3.6 11.8 7.2 110 72 578 0 -
14 M 10 4 3.3 5.3 10.27 11 20 5.4 314 40 +
15 F 5 25 6.5 7.4 9.3 8.4 138 181 401 80 +
Mean values 3.5 13.6 7.2 4.9 11.4 9.7 60 58.6 458 51.4
t-test p value ns ns 0.004 0.002 0.056 0.049 0.029 0.03 0.12 - -

ANA, anti-nuclear antibodies; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; Hb, haemoglobin; ns, not statistically significant at P ≥0.05; PC, platelet count;; RF, rheumatoid factor; *VAS, visual analogue scale; WCC, white cell count.

Finnegan et al.

Finnegan et al. Arthritis Research & Therapy 2014 16:R8   doi:10.1186/ar4434

Open Data